Develops therapies that use ultrasound-based delivery to transport genetic material safely and enable targeted, repeatable treatment approaches.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
SonoThera develops biotechnology solutions that deliver genetic medicines using a proprietary, nonviral ultrasound-based platform. It enables targeted, non-invasive delivery of DNA and RNA therapies across different parts of the body while supporting repeat dosing and minimizing safety risks. The company focuses on advancing next-generation treatments by improving how genetic material is transported and expressed within cells.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
Foothill Ventures
Medical Excellence Capital
Eli Lilly & Company
Johnson & Johnson Development Corp (JJDC)
ARCH Venture Partners
Alexandria Venture Investments
Lifespan Investments
Vertex Ventures
Formic Ventures
Illumina
Wilson Sonsini Investments (WS Investments)
SonoThera Valuations & Financials
View real-time NPM data on SonoThera stock including daily SonoThera stock price estimates, valuation history, and historical share price information. Access SonoThera financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track SonoThera pricing across six independent market signals. Looking for private company due diligence data sources on SonoThera? Get in touch to learn more.
Similar Companies
like SonoThera
FAQ
We have answers
SonoThera stock does not trade on public stock exchanges. SonoThera stock is considered a private security and you need to be an accredited investor to trade shares. To invest in SonoThera stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
SonoThera Stock does not trade on public stock exchanges. In order to sell SonoThera shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
SonoThera does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view SonoThera share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for SonoThera stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell SonoThera stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in SonoThera stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
SonoThera is a private company and has not had an IPO. There is currently no SonoThera IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to SonoThera IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
